WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Inc Stock Ownership - Who owns Arcutis Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcutis Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Howard G. WelgusDirector2025-12-0110,000$30.21
$302.13kSell
Masaru MatsudaReporting Persons title SVP General Counsel and Corporate Secretary2025-12-011,657$30.23
$50.09kSell
Suejean LinDirector2025-11-2418,052$8.63
$155.79kBuy
Todd WatanabeReporting Persons title President and Chief Executive Officer2025-11-2448,945$30.36
$1.49MSell
Suejean LinDirector2025-11-2425,272$30.78
$777.95kSell
Suejean LinDirector2025-11-247,220$7.51
$54.22kBuy
Todd WatanabeReporting Persons title President and Chief Executive Officer2025-11-211,055$30.00
$31.65kSell
Halley E. GilbertDirector2025-11-2012,220$7.51
$91.77kBuy
Halley E. GilbertDirector2025-11-2016,532$27.55
$455.44kSell
Masaru MatsudaReporting Persons title SVP General Counsel and Corporate Secretary2025-11-191,561$28.50
$44.49kSell

1 of 10

ARQT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARQT insiders and whales buy or sell their stock.

ARQT Shareholders

What type of owners hold Arcutis Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Heron15.86%19,430,454$606.23MInsider
Jennison Associates LLC10.00%12,254,119$382.33MInstitution
Rubric Capital Management LP8.78%10,749,457$335.38MInstitution
Suvretta Capital Management LLC8.55%10,478,000$326.91MInstitution
Frazier Life Sciences Management LP8.06%9,874,511$308.08MInstitution
Frazier Life Sciences VIII LP7.22%8,838,534$275.76MInsider
Blackrock Inc7.00%8,573,995$267.51MInstitution
Vanguard Group Inc5.83%7,146,090$222.96MInstitution
Polar Capital Holdings PLC4.33%5,298,754$165.32MInstitution
State Street Corp3.79%4,641,315$144.81MInstitution

1 of 3

ARQT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARQT76.71%23.29%Net SellingNet Selling
NAMS74.81%25.19%Net SellingNet Buying
IMVT48.27%51.73%Net BuyingNet Selling
LGND28.36%71.64%Net SellingNet Selling
CNTA90.29%9.71%Net SellingNet Selling
View Top Biotech Stocks

Arcutis Biotherapeutics Stock Ownership FAQ

Who owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics (NASDAQ: ARQT) is owned by 102.68% institutional shareholders, 31.18% Arcutis Biotherapeutics insiders, and 0.00% retail investors. Patrick J. Heron is the largest individual Arcutis Biotherapeutics shareholder, owning 19.43M shares representing 15.86% of the company. Patrick J. Heron's Arcutis Biotherapeutics shares are currently valued at $606.23M.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.